Iquest Enterprises News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Iquest enterprises. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Iquest Enterprises Today - Breaking & Trending Today

Edelweiss fund: Edelweiss fund to back Matrix Lab founder's buyout of Viatris API biz

Kotak is lending $150 million (₹1,250 crore) under a mezzanine debt facility to Prasad at 18-20% and arranging an additional $300 million from other lenders including Edelweiss Domestic Performing Credit Fund, two people close to the development said. The Edelweiss fund is lending the money, a senior debt facility, at 10-11%. ....

Andhra Pradesh , United States , Nimmagadda Prasad , Edelweiss Domestic Performing Credit Fund , Prasad Iquest Enterprises , Kotak Strategic Situations Fund , Kotak Group , Edelweiss Alternatives , Matrix Laboratories , Strategic Situations Fund , Iquest Enterprises , Edelweiss Fund , Matrix Lab Founder , Viatris Api Biz , Pharma Acquisition , Debt Facility ,

Kotak Fund: Kotak Fund to part finance matrix lab founder's Viatris buy

The fund plans to provide a $150 million mezzanine debt facility at 18-20% and arrange another $300 million from other lenders to finance the acquisition, said a person in the know. "The funding cost could vary by the instrument where the blend-in cost could be 14-15%," he added. ....

Andhra Pradesh , Brijesh Aggarwal , Nimmagadda Prasad , Kotak Special Situation Fund , Kotak Group , Kotak Strategic Situations Fund , Kotak Strategic Situations India Fund , Iquest Enterprises , Viney Corporation , Matrix Laboratories , Biocon Biologic , Synergy Capital , Special Situation Fund , Bankruptcy Code ,

Saraf And Partners, Viatris, Women's Healthcare Business, Active Pharmaceutical Ingredients

Global healthcare leader Viatris, (formerly known as Mylan), has taken a significant step towards its strategic goals by entering into agreements on October 1st to divest key business segments,. ....

Bikash Jhawar , Akshayys Nanda , Alex Koshy , Amit Gupta , Insud Pharma , Mohit Saraf , Lakshay Jain , Firm Founder , India To Iquest Enterprises , Srikari Kancherla Associates , Iquest Enterprises , Managing Partner , Senior Partner Bikash Jhawar , Partner Nipun Vaid , Navomi Koshy , Principal Associate , Srikari Kancherla , Sahil Arora , Foreign Direct Investment , Saraf And Partners , Omens Healthcare Business , Active Pharmaceutical Ingredients ,

Kotak Fund to invest ₹1,600 crore in Nimmagadda Prasad's API business

Kotak Strategic Situations Fund (KSSF) plans to invest around ₹1,600 crore in the active pharmaceutical ingredients (API) business acquired by Nimmagadda Prasad. The fund will support the acquisition through a $200 million funding, provided through a mix of structured debt and equity. Deutsche Bank and DBS have also reportedly financed the acquisition. ....

Nimmagadda Prasad , Kotak Strategic Situations Fund , Healthcare Management Analytics Programme , Iquest Enterprises , Kotak Special Situation Fund , Sanghi Industries , Gold Plus Glass Industry Ltd , Offering College , Chain Solutions , Deutsche Bank , Kotak Group , Spokespersons Of Iquest Enterprises , Healthcare Expertise , Matrix Laboratories , Kotak Investment Advisors , Sify Infinit Spaces , Investment Advisors , Famy Care , Kotak Fund , Api Business , Tvs Supply Chain Solutions , Ags Transact Technologies ,

IQuest Enterprises acquires Viatris' Indian API operations

IQuest Enterprises has entered into a definitive agreement to acquire the API operations of global pharmaceutical major Viatris in India ....

Andhra Pradesh , Gunupati Swathi Reddy , Nimmagadda Prasad , Iquest Enterprises , Iquest Enterprises , Matrix Labs , Executive Director , Celon Laboratories , Chief Advisor , Matrix Laboratories ,